insights_auto
Why is ORX up 5.76%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 0.90
arrow_upward
+5.76%(+0.049) 1D
Nov 17, 5:29:55 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 0.83
High
SEKÂ 0.98
Low
SEKÂ 0.83
Mkt. cap
315.79M
Avg. vol.
790.03K
Volume
719.07K
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 0.83
High
SEKÂ 0.98
Low
SEKÂ 0.83
Mkt. cap
315.79M
Avg. vol.
790.03K
Volume
719.07K
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Fox Business
·
42 minutes ago
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
MarketWatch
·
17 minutes ago
The S&P 500 is testing a key technical floor. Is it time to buy, or brace for a bear market?
BigGo Finance
·
3 hours ago
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
ChartMill
·
1 hour ago
S&P 500 Most Active Stocks for Nov. 17, 2026
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com